Nurse Practitioner, Primary Care · Lagrange, GA
NPI
1902842263
Since 2006
Specialty
Nurse Practitioner, Primary Care
Code 363LP2300X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
303 Smith Street, Clark-Holder Clinic, P.A.
Lagrange, GA, 30240
Phone (706) 882-8831
Groups this clinician bills Medicare through
Medicare paid, 2024
$25K
382 services
Medicare patients, 2024
248
Average age 72
Drug cost, 2024
$1.4M
3,356 prescriptions
Company payments, 2025
$1,581
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Candace H Wortham was code 99214 (office e&m - established), 196 times for 136 patients. In total Candace H Wortham billed 382 services in 7 codes, and Medicare paid $25K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 196 | 136 | $73.92 | $14K |
| 99213 Office E&M - Established | Office | 156 | 132 | $50.58 | $7,890 |
| 99204 Office E&M - New | Office | 21 | 21 | $94.24 | $1,979 |
By year: 2022 $20K for 362 services; 2023 $27K for 428 services; 2024 $25K for 382 services.
Medicare prescription drug claims, 2024
In 2024, the drug Candace H Wortham prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 774 prescriptions and refills. In total Candace H Wortham wrote 3,356 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 774 | 894 | 250 | $21K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 679 | 816 | 131 | $523K |
| Montelukast Sodium Generic | 276 | 620 | 89 | $1,907 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 259 | 315 | 73 | $198K |
| Advair Hfa Fluticasone Propion/Salmeterol | 217 | 267 | 51 | $111K |
| Spiriva Respimat Tiotropium Bromide | 123 | 149 | 26 | $74K |
| Symbicort Budesonide/Formoterol Fumarate | 121 | 167 | 25 | $37K |
| Ventolin Hfa Albuterol Sulfate | 103 | 114 | 40 | $6,529 |
| Fluticasone Propionate Generic | 99 | 193 | 38 | $1,194 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 79 | 108 | 28 | $14K |
| Breo Ellipta Fluticasone/Vilanterol | 69 | 102 | 14 | $40K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 51 | 52 | Under 11 | $24K |
| Wixela Inhub Fluticasone Propion/Salmeterol | 49 | 58 | 13 | $7,645 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 48 | 51 | 11 | $8,292 |
| Incruse Ellipta Umeclidinium Bromide | 42 | 44 | Under 11 | $15K |
Brand drugs: 2,298 claims; generic drugs: 1,046 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Candace H Wortham $1,581 ($1,581 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $342.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 17 | $342 |
| GlaxoSmithKline, LLC. GSK | 18 | $236 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $185 |
| Genzyme Corporation SNY | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 5 | $93.94 |
| Verona Pharma, Inc. VRNA | 4 | $86.15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $67.54 |
| Philips North America LLC PHG | 3 | $64.08 |
| Janssen Biotech, Inc. JNJ | 3 | $63.5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.